(a) Adjusted results exclude accelerated depreciation on manufacturing assets to be abandoned due to facility consolidations. Adjusted results in 2025 exclude $5 of charges for the sale of inventory ...

The "Enterprise Tech Ecosystem Series: Thermo Fisher Scientific - 2025" company profile has been added to ResearchAndMarkets.com's offering. The report offers detailed information and insights into ...

Shares of Thermo Fisher Scientific Inc. (TMO) were in the spotlight on Wednesday after the company reported upbeat first-quarter (Q1) earnings but slashed its annual earnings guidance. For the three ...

Thermo Fisher Scientific (TMO) reported $10.36 billion in revenue for the quarter ended March 2025, representing a year-over-year increase of 0.2%. EPS of $5.15 for the same period compares to $5.11 a ...

It has been about a month since the last earnings report for Thermo Fisher Scientific (TMO). Shares have added about 0.2% in that time frame, outperforming the S&P 500. But investors have to be ...

Reports Q3 revenue $10.6B, consensus $10.64B. “We are pleased to deliver strong financial results in the third quarter, reflecting another quarter of sequential improvement in growth,” said Marc N.

Thermo Fisher Scientific Inc. TMO is slated to release third-quarter 2021 results on Oct 20, before market open. In the last reported quarter, the company’s earnings of $5.60 per share exceeded the ...

Second quarter revenue grew 3% to $10.85 billion. Second quarter GAAP diluted earnings per share (EPS) grew 6% to $4.28. Second quarter adjusted EPS was $5.36. Delivered excellent operational ...

(a) Adjusted results exclude accelerated depreciation on manufacturing assets to be abandoned due to facility consolidations and charges for the sale of inventory revalued at the date of acquisition.

In addition to the financial measures prepared in accordance with generally accepted accounting principles (GAAP), we use certain non-GAAP financial measures such as organic revenue growth, which is ...